Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
24/11/2021

Archive: 24/11/2021

Study finds gradual increase in COVID infection risk after second vaccine dose

A study published by The BMJ today finds a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.

Nov 24, 2021

7

998

Proposed changes to UK law risk increasing financial abuse of older people, warn experts

Proposed changes to UK law risk substantially increasing financial abuse of older people, warn experts in The BMJ today.

Nov 24, 2021

0

15

Extreme heat may affect young and middle-aged adults more than the elderly: study

Extreme heat—a leading cause of weather-related deaths in the United States—poses an increasing threat to the public, as days of extreme heat are expected to become more frequent, more intense, and longer-lasting due ...

Nov 24, 2021

0

2

Belzutifan induced strong responses in patients with von Hippel-Lindau disease-associated kidney cancer

Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center showed that treatment with belzutifan, a small-molecule inhibitor of hypoxia-inducible factor (HIF)-2a, achieved strong ...

Nov 24, 2021

0

21

Study finds brain lesions on MRI linked to years of playing football

Certain markers of injury to the brain's white matter, called white matter hyperintensities, can be seen on brain scans. A new study finds that brain scans taken during the lifetimes of athletes in contact sports, compared ...

Nov 24, 2021

0

5

Italy targets unvaccinated with restrictions as cases rise

The Italian government on Wednesday decided to exclude unvaccinated people from certain leisure activities in a bid to contain rising coronavirus infections and stave off financially crippling lockdowns just as the economy ...

Nov 24, 2021

0

2

Hypoxia tolerance: Naked mole-rats may provide secret to low oxygen survival

Researchers at the University of Ottawa have discovered how the naked mole-rat can save energy in hypoxia and survive in low oxygen conditions. The mechanism by which these wrinkled, nearly hairless African mammals tolerate ...

Nov 24, 2021

0

2

Researchers find new target to combat lung disease

Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive ...

Nov 24, 2021

0

159

UK study suggests COVID-19 became much more lethal in late 2020

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors—not just the alpha variant of the virus that causes COVID-19—were to blame. ...

Nov 24, 2021

0

137

Experimental compound counters diabetic complications

An experimental compound reduced complications of type 1 and type 2 diabetes in mice—not by lowering blood sugar—but by countering its consequences: cell death, inflammation, and organ damage.

Nov 24, 2021

0

67

page 1 from 9

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us